Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Perkins

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Journal of Psychopathology and Clinical Science|February 6, 2025
Delineating empirically plausible causal pathways to suicidality among people at clinical high risk for psychosisMichael V Bronstein, Erich Kummerfeld, Carrie E Bearden, et al.
The American Journal of Psychiatry|May 2, 2006
Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosisThomas H McGlashan, Robert B Zipursky, Diana Perkins, et al.
Archives of General Psychiatry|April 6, 2005
Antipsychotic drug effects on brain morphology in first-episode psychosisJeffrey A Lieberman, Gary D Tollefson, Cecil Charles, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 27, 2015
At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis predictionPaolo Fusar-Poli, Marco Cappucciati, Grazia Rutigliano, et al.
Schizophrenia Research|February 13, 2019
Adding a neuroanatomical biomarker to an individualized risk calculator for psychosis: A proof-of-concept studyYoonho Chung, Jean Addington, Carrie E Bearden, et al.
JAMA Psychiatry|July 5, 2018
Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High RiskYoonho Chung, Jean Addington, Carrie E Bearden, et al.
Neuroimage. Clinical|June 1, 2019
Cortical abnormalities in youth at clinical high-risk for psychosis: Findings from the NAPLS2 cohortYoonho Chung, Dana Allswede, Jean Addington, et al.
Schizophrenia Research|March 2, 2017
Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosisYoonho Chung, Kristen M Haut, George He, et al.
Brain, Behavior, and Immunity|January 14, 2024
Differential expression of haptoglobin in individuals at clinical high risk of psychosis and its association with global functioning and clinical symptomsColm Healy, Jonah Byrne, Subash Raj Suasi, et al.
Molecular Neuropsychiatry|May 26, 2015
Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion Among Clinically High Risk Youth Developing Psychotic DisordersYoonho Chung, Aron Jacobson, George He, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Journal of Psychopathology and Clinical Science|February 6, 2025
Delineating empirically plausible causal pathways to suicidality among people at clinical high risk for psychosisMichael V Bronstein, Erich Kummerfeld, Carrie E Bearden, et al.
The American Journal of Psychiatry|May 2, 2006
Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosisThomas H McGlashan, Robert B Zipursky, Diana Perkins, et al.
Archives of General Psychiatry|April 6, 2005
Antipsychotic drug effects on brain morphology in first-episode psychosisJeffrey A Lieberman, Gary D Tollefson, Cecil Charles, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 27, 2015
At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis predictionPaolo Fusar-Poli, Marco Cappucciati, Grazia Rutigliano, et al.
Schizophrenia Research|February 13, 2019
Adding a neuroanatomical biomarker to an individualized risk calculator for psychosis: A proof-of-concept studyYoonho Chung, Jean Addington, Carrie E Bearden, et al.
JAMA Psychiatry|July 5, 2018
Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High RiskYoonho Chung, Jean Addington, Carrie E Bearden, et al.
Neuroimage. Clinical|June 1, 2019
Cortical abnormalities in youth at clinical high-risk for psychosis: Findings from the NAPLS2 cohortYoonho Chung, Dana Allswede, Jean Addington, et al.
Schizophrenia Research|March 2, 2017
Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosisYoonho Chung, Kristen M Haut, George He, et al.
Brain, Behavior, and Immunity|January 14, 2024
Differential expression of haptoglobin in individuals at clinical high risk of psychosis and its association with global functioning and clinical symptomsColm Healy, Jonah Byrne, Subash Raj Suasi, et al.
Molecular Neuropsychiatry|May 26, 2015
Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion Among Clinically High Risk Youth Developing Psychotic DisordersYoonho Chung, Aron Jacobson, George He, et al.
Pageof 4